140 related articles for article (PubMed ID: 25682080)
21. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T
Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522
[TBL] [Abstract][Full Text] [Related]
22. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
Ilan N; Elkin M; Vlodavsky I
Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
[TBL] [Abstract][Full Text] [Related]
23. Tumor metastasis-associated heparanase (heparan sulfate endoglycosidase) activity in human melanoma cells.
Nakajima M; Irimura T; Nicolson GL
Cancer Lett; 1986 Jun; 31(3):277-83. PubMed ID: 3719568
[TBL] [Abstract][Full Text] [Related]
24. P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins.
Hostettler N; Naggi A; Torri G; Ishai-Michaeli R; Casu B; Vlodavsky I; Borsig L
FASEB J; 2007 Nov; 21(13):3562-72. PubMed ID: 17557930
[TBL] [Abstract][Full Text] [Related]
25. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
[TBL] [Abstract][Full Text] [Related]
26. Supersulfated low-molecular weight heparin synergizes with IGF1R/IR inhibitor to suppress synovial sarcoma growth and metastases.
Cassinelli G; Dal Bo L; Favini E; Cominetti D; Pozzi S; Tortoreto M; De Cesare M; Lecis D; Scanziani E; Minoli L; Naggi A; Vlodavsky I; Zaffaroni N; Lanzi C
Cancer Lett; 2018 Feb; 415():187-197. PubMed ID: 29225052
[TBL] [Abstract][Full Text] [Related]
27. Modulation of GEF-H1 induced signaling by heparanase in brain metastatic melanoma cells.
Ridgway LD; Wetzel MD; Marchetti D
J Cell Biochem; 2010 Dec; 111(5):1299-309. PubMed ID: 20803552
[TBL] [Abstract][Full Text] [Related]
28. Dominant-negative CREB inhibits heparanase functionality and melanoma cell invasion.
Aucoin R; Reiland J; Roy M; Marchetti D
J Cell Biochem; 2004 Oct; 93(2):215-23. PubMed ID: 15368349
[TBL] [Abstract][Full Text] [Related]
29. Spreading and focal contact formation of human melanoma cells in response to the stimulation of both melanoma-associated proteoglycan (NG2) and alpha 4 beta 1 integrin.
Iida J; Meijne AM; Spiro RC; Roos E; Furcht LT; McCarthy JB
Cancer Res; 1995 May; 55(10):2177-85. PubMed ID: 7743521
[TBL] [Abstract][Full Text] [Related]
30. Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin.
Han J; Hiebert LM
Vascul Pharmacol; 2013; 59(3-4):112-8. PubMed ID: 23939434
[TBL] [Abstract][Full Text] [Related]
31. Contribution of very late antigen-4 (VLA-4) integrin to cancer progression and metastasis.
Schlesinger M; Bendas G
Cancer Metastasis Rev; 2015 Dec; 34(4):575-91. PubMed ID: 25564456
[TBL] [Abstract][Full Text] [Related]
32. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
[TBL] [Abstract][Full Text] [Related]
33. Heparanase affects adhesive and tumorigenic potential of human glioma cells.
Zetser A; Bashenko Y; Miao HQ; Vlodavsky I; Ilan N
Cancer Res; 2003 Nov; 63(22):7733-41. PubMed ID: 14633698
[TBL] [Abstract][Full Text] [Related]
34. Suppression of endoplasmic reticulum stress-induced invasion and migration of breast cancer cells through the downregulation of heparanase.
Li Y; Liu H; Huang YY; Pu LJ; Zhang XD; Jiang CC; Jiang ZW
Int J Mol Med; 2013 May; 31(5):1234-42. PubMed ID: 23467544
[TBL] [Abstract][Full Text] [Related]
35. Heparanase in Cancer Metastasis - Heparin as a Potential Inhibitor of Cell Adhesion Molecules.
Bendas G; Borsig L
Adv Exp Med Biol; 2020; 1221():309-329. PubMed ID: 32274715
[TBL] [Abstract][Full Text] [Related]
36. Low molecular weight heparin inhibits melanoma cell adhesion and migration through a PKCa/JNK signaling pathway inducing actin cytoskeleton changes.
Chalkiadaki G; Nikitovic D; Katonis P; Berdiaki A; Tsatsakis A; Kotsikogianni I; Karamanos NK; Tzanakakis GN
Cancer Lett; 2011 Dec; 312(2):235-44. PubMed ID: 21906873
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of extracellular superoxide dismutase attenuates heparanase expression and inhibits breast carcinoma cell growth and invasion.
Teoh ML; Fitzgerald MP; Oberley LW; Domann FE
Cancer Res; 2009 Aug; 69(15):6355-63. PubMed ID: 19602586
[TBL] [Abstract][Full Text] [Related]
38. The heparanase/heparan sulfate proteoglycan axis: A potential new therapeutic target in sarcomas.
Cassinelli G; Zaffaroni N; Lanzi C
Cancer Lett; 2016 Nov; 382(2):245-254. PubMed ID: 27666777
[TBL] [Abstract][Full Text] [Related]
39. CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1).
Wang HS; Hung Y; Su CH; Peng ST; Guo YJ; Lai MC; Liu CY; Hsu JW
Exp Cell Res; 2005 Mar; 304(1):116-26. PubMed ID: 15707579
[TBL] [Abstract][Full Text] [Related]
40. Heparanase expression in B16 melanoma cells and peripheral blood neutrophils before and after extravasation detected by novel anti-mouse heparanase monoclonal antibodies.
Komatsu N; Waki M; Sue M; Tokuda C; Kasaoka T; Nakajima M; Higashi N; Irimura T
J Immunol Methods; 2008 Feb; 331(1-2):82-93. PubMed ID: 18162185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]